Kontakte Nou
Lendi - vandredi, 8 a.m. jiska 5 p.m.
Our Multidisciplinary Approach
Boston Medical Center (BMC) is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases caused by the abnormal accumulation of the protein amyloid in various parts of the body. Sa a ka rive kòm yon pati nan yon maladi selil mwèl zo (AL), kòm yon fòm ereditè (AF), yon fòm ki gen rapò ak laj (senile amyloidosis sistemik akòz ATTR), oswa ki rive akoz anflamasyon kwonik oswa maladi trapan (AA).
In conjunction with the Boston University Chobanian & Avedisian School of Medicine, the Amyloidosis Center at BMC offers a multidisciplinary approach to diagnosis and treatment of this multi-organ disorder. Under the direction of Vaishali Sanchorawala, MD, the Center is unique in its approach, providing exceptional care for patients with all forms of systemic and localized amyloidosis through the support of laboratory and clinical research.
Because the disease frequently involves more than one organ system, BMC offers a multispecialty evaluation for patients. This three-day outpatient evaluation is comprised of tests and consultations that help determine the amyloid type and organ system involvement. Pasyan yo gide nan chak etap nan evalyasyon an, e doktè ak enfimyè esplike rezon ki fè yo fè chak tès ak sa rezilta yo vle di. Kou evalyasyon an fini, yo devlope yon plan tretman devlope.
Specialists in hematology-oncology, cardiovascular medicine, gastroenterology, kidney (renal) medicine, neurology, otolaryngology, pathology and laboratory medicine, pulmonary medicine, radiation oncology, and urology coordinate to evaluate patients and develop care plans.
Sèvis konsiltasyon medikal ak patolojik disponib tou pou pasyan yo ak doktè yo.
Please visit BU’s Amyloidosis Center website for more information about the different types of amyloidosis, the patient evaluation process, and consultation services.
Ekip Nou an
The BMC amyloidosis clinical team is a multidisciplinary group of physicians. Chak espesyalis nan lòt domèn yon ekspè ameriken e li te wè plizyè santèn pasyan ki gen amiloyidoz.
Vaishali Sanchorawala, MD
John L. Berk, MD
Sonia Ananthakrishnan, MD
Eric J. Burks, MD
Margaux Dockerty Martin, NP
Sophia (Sophie) Z. Grimes, MSN, RN, FNP-C
Andrea I. Havasi, MD
Shabatun J. Islam, MD
Kwan Hon Vincent Lau, MD
Caryn A. Libbey, MD
Hanni Menn-Josephy, MD
Frederick L. Ruberg, MD
Omar K. Siddiqi, MD
J. Mark Sloan, MD
Apèsi sou rechèch
Pasyan ki gen amiloyidoz yo te imedyatman ede atravè avans ki sòti nan pwogram rechèch laboratwa ak tradiksyonèl ki kowòdone pa envestigatè klinik nan BMC ak envestigatè laboratwa nan Boston University Chobanian & Avedisian School of Medicine. The Amyloidosis Center at the Boston University Chobanian & Avedisian School of Medicine has been in existence since 1960, and has been responsible for many advances in the field, including some of the first randomized treatment trials, stem-cell transplant trials, trials with novel agents and small molecules, and protocols for liver and heart transplantation for selected patients.